Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.000
+0.010 (0.25%)
Mar 31, 2025, 10:53 AM EDT - Market open
Cytek Biosciences Employees
Cytek Biosciences had 648 employees as of December 31, 2024. The number of employees decreased by 28 or -4.14% compared to the previous year.
Employees
648
Change (1Y)
-28
Growth (1Y)
-4.14%
Revenue / Employee
$309,341
Profits / Employee
-$9,290
Market Cap
512.39M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 648 | -28 | -4.14% |
Dec 31, 2023 | 676 | 93 | 15.95% |
Dec 31, 2022 | 583 | 81 | 16.14% |
Dec 31, 2021 | 502 | 111 | 28.39% |
Dec 31, 2020 | 391 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
CTKB News
- 12 days ago - Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System - GlobeNewsWire
- 4 weeks ago - Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript - Seeking Alpha
- 4 weeks ago - Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook - GlobeNewsWire
- 6 weeks ago - Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewsWire
- 7 weeks ago - Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Upgrading Cytek Biosciences Stock On An Upcoming Catalyst - Seeking Alpha
- 3 months ago - Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025 - GlobeNewsWire